Detalles de la búsqueda
1.
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.
Am J Hematol
; 98(4): 645-657, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36606708
2.
Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies.
Cancer
; 128(17): 3185-3195, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35737639
3.
Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C Mutation.
Oncologist
; 27(7): 536-e553, 2022 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35325211
4.
First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours.
Br J Cancer
; 123(8): 1235-1243, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32741971
5.
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?
Br J Cancer
; 119(8): 937-939, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30327567
6.
Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience.
Breast J
; 24(4): 473-479, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29286192
7.
Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer.
Br J Cancer
; 115(6): 655-63, 2016 09 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27537382
8.
Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors.
JCO Precis Oncol
; 7: e2200583, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36862966
9.
Radiological patterns of tumour progression in patients treated with a combination of immune checkpoint blockers and antiangiogenic drugs.
Eur J Cancer
; 167: 42-53, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35378410
10.
Epigenetic gene alterations in metastatic solid tumours: results from the prospective precision medicine MOSCATO and MATCH-R trials.
Eur J Cancer
; 173: 133-145, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35872509
11.
Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved Test.
Cells
; 11(12)2022 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35741030
12.
Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology.
JCO Precis Oncol
; 6: e2100484, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36315916
13.
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.
Nat Cancer
; 3(2): 251-261, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35221333
14.
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers.
J Exp Clin Cancer Res
; 41(1): 217, 2022 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35794623
15.
Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score.
Cancers (Basel)
; 14(20)2022 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36291861
16.
PALLIA 10 score in phase I cancer studies.
BMJ Support Palliat Care
; 2022 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36041820
17.
Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?
Front Immunol
; 12: 745146, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34804027
18.
Absence of significant clinical benefit for a systematic routine creatine phosphokinase measurement in asymptomatic patients treated with anti-programmed death protein (ligand) 1 immune checkpoint inhibitor to screen cardiac or neuromuscular immune-related toxicities.
Eur J Cancer
; 157: 383-390, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34571335
19.
Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors.
Cancers (Basel)
; 13(15)2021 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34359675
20.
Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma.
Clin Cancer Res
; 27(2): 438-446, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33046517